Journal
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Volume 153, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.biocel.2022.106315
Keywords
Gastric cancer; Epigenetics; DNA methylation; Histone modification; A; B parts; TADs; Loops
Categories
Funding
- National Natural Science Foundation of China
- Tianjin Science and Technology Plan Project
- [32100418]
- [20JCZDJC00550]
Ask authors/readers for more resources
Gastric cancer, a common malignant tumor of the digestive tract, exhibits high malignancy and poor prognosis. Epigenetic changes, such as DNA methylation and histone modification, play a crucial role in its pathogenesis. Utilizing new technologies can aid in early diagnosis and treatment of gastric cancer patients.
Gastric cancer is one of the most common malignant tumors of the digestive tract, with a high degree of malignancy and poor prognosis. With advancements in disease research, the role of epigenetic changes in its pathogenesis has become a research focus. The known epigenetic changes mainly include DNA methylation, histone modification, and regulation of chromatin structure. This article details the effects of these changes that would result in gastric cancer. Using next-generation sequencing methods and bioinformatics analysis, we can determine the epigenetic changes in abnormal tissues of the digestive tract that facilitate the early diagnosis and treatment of gastric cancer patients. In this article, we summarize how epigenetic changes determine gastric cancer and the new technologies used in research on cancer to benefit gastric cancer patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available